Privia Health Group, Inc. - PRVA STOCK NEWS

Privia Health Group (Nasdaq: PRVA) has scheduled the release of its first quarter 2025 financial results for Thursday, May 8, 2025, before market open. The results announcement is planned for 7:00 am ET and will be available on the company's Investor Relations website.

Management will host a conference call at 8:00 am ET on the same day to discuss Q1 2025 results and provide insights on future financial and operational performance outlook. Investors can access the live webcast through the company's IR website, with an archived version available for replay after the call. For direct participation, attendees can dial 888-596-4144 (US) or 646-968-2525 (international) using Conference ID 5704885.

Privia Health (PRVA) reported strong financial results for Q4 and full-year 2024, exceeding all operating and financial metrics guidance ranges. Key highlights include:

- Implemented Providers grew 11.2% from 2023
- Fee-for-service collections increased 13.6% year-over-year
- Medicare Shared Savings Program (MSSP) generated $176.6M in savings, up 34.1% from 2022
- Adjusted EBITDA grew 25.2% compared to 2023
- Net Cash from Operations reached $109.3M, increasing 35.3% from 2023
- Free Cash Flow of $109.3M, representing 121% of Adjusted EBITDA

The company ended 2024 with a strong balance sheet showing $491.1M in cash and no debt, up 26.1% from $389.5M in 2023. For 2025, Privia expects continued momentum despite challenging Medicare Advantage market conditions.

Privia Health Group (Nasdaq: PRVA) has announced it will release its fourth quarter and full-year 2024 financial results before market open on Thursday, February 27, 2025. The press release will be disseminated by 7:00 am ET and will be available on the company's Investor Relations website.

Management will host a conference call at 8:00 am ET on the same day to discuss results and provide outlook on future financial and operational performance. Investors can access the live webcast through the company's IR website, with an archived version available for replay after the call. For those joining by phone, the dial-in number is 646-968-2525 (888-596-4144 for international callers) with Conference ID 5704885.

Privia Health (NASDAQ: PRVA) reported strong Q3 2024 financial results with total revenue increasing 4.9% to $437.9 million. The company showed significant growth across key metrics, with Adjusted EBITDA rising 25.8% to $23.6 million. Implemented providers grew 13.1% to 4,642, while value-based care attributed lives increased 14.0% to 1.247 million. The company's ACOs achieved $176.6 million in MSSP shared savings, up 34.1% from 2022. Privia maintains a strong financial position with $422.0 million in cash and no debt. Based on performance, the company raised its full-year 2024 guidance to at or above the high end for all metrics.

Privia Health Group (Nasdaq: PRVA) announced that its Accountable Care Organizations (ACOs) achieved $176.6 million in shared savings through the Medicare Shared Savings Program (MSSP) for 2023, a 34.1% increase from 2022. The company's 10 ACOs managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers serving 194,786 Medicare beneficiaries. Notable achievements include a 7.6% aggregate savings rate, beneficiary expenditures 8% lower than median ACO, and emergency department visits 16% lower than median ACO. Since 2014, Privia Quality Network has delivered total shared savings of over $1.2 billion across various programs.

Privia Health Group, Inc. (Nasdaq: PRVA) has announced its plan to release financial results for the third quarter and nine-month periods ended September 30, 2024. The release is scheduled for Thursday, November 7, 2024, before market open, with the press release expected to be disseminated by 7:00 am ET. The financial results will also be available on the company's Investor Relations website.

Following the release, Privia Health management will host a conference call at 8:00 am ET on November 7 to discuss the results and provide insights on future financial and operational performance. Investors and interested parties can participate in the call via live webcast or by dialing in. The webcast will be archived for on-demand listening after the call.

Privia Health Group (Nasdaq: PRVA) reported strong Q2 2024 financial results, with notable growth across key metrics. Total revenue increased 2.2% to $422.3 million, while gross profit rose 8.9% to $98.3 million. The company saw a 16.4% increase in implemented providers to 4,504 and a 10.7% growth in value-based care attributed lives to 1.2 million. Adjusted EBITDA grew 14% to $22 million, and non-GAAP adjusted net income increased 13% to $23.5 million.

Based on strong performance, Privia Health raised its full-year 2024 guidance to the mid to high end for all metrics. The company maintains a robust financial position with $387.4 million in cash and no debt. These results demonstrate Privia Health's continued execution and growth in the healthcare sector.

Privia Health Group (Nasdaq: PRVA) will release its financial results for Q2 and the six-month period ending June 30, 2024, on August 8, 2024, before market open. The press release will be available on the company's Investor Relations website, expected by 7:00 am ET. Management will host a conference call at 8:00 am ET the same day to discuss the results and future outlook. The call will be accessible via live webcast and archived for replay on the Investor Relations site. Dial 800-715-9871 (646-307-1963 for international) with Conference ID 2580381 to join the live call.

Privia Health Group announced that Privia Medical Group received the 2024 MAP Award for High Performance in Revenue Cycle from the Healthcare Financial Management Association (HFMA). This marks the eighth recognition in nine years for the group, highlighting its robust revenue cycle capabilities and adherence to industry standards. The award was presented on June 24 at the HFMA Annual Conference in Las Vegas. Privia's success is attributed to its implementation of HFMA's Healthcare Dollars & Sense® initiatives, which focus on patient-centered best practices and benchmarks. The achievement underscores the dedication of Privia's physicians and staff to operational excellence and patient satisfaction.